Robert Alexander Ingram's Net Worth

$102 Million

Estimate Recalculated Jul 19, 2024 03:36PM EST

Who is Robert Alexander Ingram?

Robert Alexander Ingram has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS INC, Valeant Pharmaceuticals International, Inc., CREE INC, BIOCRYST PHARMACEUTICALS INC, NORTEL NETWORKS CORP, PhaseBio Pharmaceuticals Inc, Novan, Inc., LOWES COMPANIES INC, Edwards Lifesciences Corp, Black Diamond Therapeutics, Inc., Clearside Biomedical, Inc., ALLERGAN INC, VALEANT PHARMACEUTICALS INTERNATIONAL, PHARMACEUTICAL PRODUCT DEVELOPMENT INC, QUINTILES TRANSNATIONAL CORP, G1 Therapeutics, Inc., WACHOVIA CORP NEW, and OSI PHARMACEUTICALS INC.

SEC CIK

Robert Alexander Ingram's CIK is 0001219890

Past Insider Trading and Trends

2008 was Robert Alexander Ingram's most active year for acquiring shares with 68 total transactions. Robert Alexander Ingram's most active month to acquire stocks was the month of August. 2007 was Robert Alexander Ingram's most active year for disposing of shares, totalling 98 transactions. Robert Alexander Ingram's most active month to dispose stocks was the month of February. 2016 saw Robert Alexander Ingram paying a total of $3,846,372.35 for 3,869,793 shares, this is the most they've acquired in one year. In 2018 Robert Alexander Ingram cashed out on 3,116,259 shares for a total of $40,454,042.57, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REGENERON PHARMACEUTICALS INC (REGN) Snapshot price: $939

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.5K
$404.60
-$707,426.54
1.5K
May 22 - May 27
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Apr 4
Form 3
—
0
—
—
0
No matching records found

Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $8.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.36%
2.12K
$11.03
$23,383.60
92.05K
Mar 31
Form 4
+1.65%
1.46K
$14.52
$21,242.76
89.93K
Dec 30
Form 4
+0.99%
865
$24.55
$21,235.75
88.46K
Sep 30
Form 4
+1.25%
1.08K
$20.14
$21,751.20
87.6K
Jun 30
Form 4
+23.97%
16.73K
—
—
86.52K
Jun 17
Form 4
+1.34%
926
—
—
69.79K
May 2
Form 4
+0.35%
239
—
—
68.87K
Dec 31
Form 4
+0.20%
136
—
—
68.63K
Sep 30
Form 4
+0.16%
109
—
—
68.49K
Jun 30
Form 4
+2.41%
1.61K
—
—
68.38K
May 22
Form 4
+0.18%
122
—
—
66.78K
Mar 31
Form 4
+4.49%
2.87K
—
—
66.65K
May 23
Form 4
-1.97%
-1.28K
$88.21
-$112,820.59
63.79K
Jun 4
Form 4
-66.15%
-127.13K
$90.81
-$11,544,493.68
65.07K
May 30
Form 4
+2.68%
5.02K
—
—
192.19K
May 24
Form 4
+4.50%
8.06K
—
—
187.17K
Jun 4
Form 4
-19.95%
-44.63K
—
—
179.11K
May 30
Form 4
+0.10%
220
—
—
223.74K
Dec 31
Form 4
+0.13%
277
—
—
220.69K
Sep 30
Form 4
+2.05%
168
—
—
8.38K
Sep 30
Form 4
+0.06%
127
—
—
220.41K
Jun 30
Form 4
+2.51%
5.4K
—
—
220.29K
May 19
Form 4/A
-4.34%
-9.87K
$40.00
-$394,880.00
217.72K
Feb 28
Form 4/A
+3.30%
7.28K
—
—
227.6K
Dec 22
Form 4/A
∞
220.32K
—
—
220.32K
Sep 28
Form 4
—
0
—
—
0
Mar 5
Form 4
-100.00%
-9.87K
$40.00
-$394,880.00
0
Feb 28
Form 4
—
0
—
—
0
Dec 22
Form 4
∞
217.58K
—
—
217.58K
Sep 28
Form 3
—
0
—
—
0
No matching records found

CREE INC (WOLF) Snapshot price: $26.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.99%
760
$39.46
$29,989.60
77.71K
Oct 17
Form 4
+5.48%
4K
$30.92
$123,680.00
76.95K
Aug 30
Form 4
+0.90%
648
$46.26
$29,976.48
72.95K
Aug 15
Form 4
+1.07%
764
$39.25
$29,987.00
72.3K
Apr 25
Form 4
+1.18%
833
$35.98
$29,971.34
71.54K
Jan 24
Form 4
+1.04%
731
$34.16
$24,970.96
70.7K
Oct 18
Form 4
+11.17%
7.03K
—
—
69.97K
Sep 1
Form 4
+1.82%
1.13K
$22.21
$24,986.25
62.94K
Aug 23
Form 4
+1.87%
1.13K
$22.07
$24,983.24
61.82K
Apr 26
Form 4
+1.45%
867
$28.83
$24,995.61
60.68K
Jan 25
Form 4
+1.90%
1.11K
$22.41
$24,987.15
59.82K
Oct 19
Form 4
+12.30%
6.43K
—
—
58.7K
Sep 1
Form 4
+2.41%
1.23K
$23.38
$28,734.02
52.27K
Aug 17
Form 4
+2.21%
1.1K
$26.00
$28,730.00
51.04K
Apr 27
Form 4
+2.24%
1.09K
$26.30
$28,745.90
49.94K
Jan 20
Form 4
—
0
$21.19
-$48,592.50
48.85K
Dec 1
Form 4
+2.52%
1.2K
$23.96
$28,728.04
48.85K
Oct 21
Form 4
+16.29%
6.67K
—
—
47.65K
Sep 1
Form 4
+2.79%
1.11K
$26.58
$29,556.96
40.97K
Aug 12
Form 4
+2.08%
811
$32.36
$26,243.96
39.86K
Apr 22
Form 4
+2.02%
775
$33.87
$26,249.25
39.05K
Jan 21
Form 4
+2.58%
962
$27.27
$26,233.74
38.27K
Oct 22
Form 4
+12.83%
4.24K
—
—
37.31K
Sep 2
Form 4
+1.19%
390
$44.81
$17,475.90
33.07K
Aug 13
Form 4
+1.06%
343
$51.01
$17,496.43
32.68K
Apr 23
Form 4
+0.69%
222
$67.30
$14,940.60
32.34K
Jan 22
Form 4
+0.76%
242
$61.75
$14,943.50
32.11K
Oct 23
Form 4
+14.35%
4K
—
—
31.87K
Sep 3
Form 4
+0.92%
255
$58.82
$14,999.10
27.87K
Aug 14
Form 4
+0.97%
265
$56.46
$14,961.90
27.62K
Apr 24
Form 4
+1.36%
367
$40.85
$14,991.95
27.35K
Jan 23
Form 4
+1.96%
518
$28.92
$14,980.56
26.98K
Oct 17
Form 4
+17.80%
4K
—
—
26.47K
Sep 4
Form 4
+2.52%
553
$27.11
$14,991.83
22.47K
Aug 8
Form 4
+2.33%
500
$29.97
$14,985.00
21.91K
Apr 18
Form 4
+2.95%
613
$24.44
$14,981.72
21.41K
Jan 18
Form 4
+2.53%
514
$24.30
$12,490.20
20.8K
Oct 19
Form 4
+24.56%
4K
—
—
20.29K
Sep 1
Form 4
+2.31%
367
$34.03
$12,489.01
16.29K
Aug 10
Form 4
+2.02%
315
$39.67
$12,496.05
15.92K
Apr 20
Form 4
+1.52%
233
$53.57
$12,481.81
15.61K
Jan 19
Form 4
+1.65%
249
$50.02
$12,454.98
15.37K
Oct 20
Form 4
+49.39%
5K
—
—
15.12K
Sep 1
Form 4
+2.11%
209
$59.78
$12,494.02
10.12K
Aug 11
Form 4
+1.68%
164
$76.19
$12,495.16
9.91K
Apr 21
Form 4
+105.26%
5K
—
—
9.75K
Sep 1
Form 4
+26.67%
1K
$18.95
$18,948.60
4.75K
Mar 6
Form 4
∞
3.75K
—
—
3.75K
Dec 29
Form 3
—
0
—
—
0
No matching records found

BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.305

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.31%
2.26K
$8.85
$19,992.15
100.2K
Feb 28
Form 4
+1.55%
1.5K
$13.36
$19,999.92
97.94K
Nov 30
Form 4
+1.51%
1.44K
$13.90
$19,988.20
96.44K
Aug 31
Form 4
+15.66%
12.87K
—
—
95K
Jun 7
Form 4
+2.60%
2.08K
$9.31
$19,346.18
82.14K
May 31
Form 4
+1.43%
1.13K
$16.61
$18,736.08
80.06K
Feb 28
Form 4
+2.01%
1.55K
$12.06
$18,741.24
78.93K
Nov 30
Form 4
+1.54%
1.18K
$15.92
$18,737.84
77.38K
Aug 31
Form 4
+1.58%
1.19K
$15.77
$18,734.76
76.2K
May 28
Form 4
—
0
—
—
0
May 25
Form 4
+2.37%
1.74K
$10.78
$18,746.42
75.01K
Feb 26
Form 4
+5.27%
3.67K
$5.11
$18,748.59
73.27K
Nov 30
Form 4
+6.94%
4.52K
$4.15
$18,749.70
69.61K
Aug 31
Form 4
+6.85%
4.17K
$4.50
$18,748.65
65.09K
Jun 1
Form 4
—
0
—
—
0
May 12
Form 4
+11.43%
6.25K
$3.00
$18,750.00
60.92K
Mar 1
Form 4
+13.68%
6.58K
$2.85
$18,747.30
54.67K
Dec 1
Form 4
+71.20%
20K
$1.45
$29,000.00
48.09K
Nov 18
Form 4
+28.74%
6.27K
$2.99
$18,747.30
28.09K
Sep 1
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Jun 20
Form 4
+15.43%
2.92K
$6.43
$18,749.88
21.82K
Jun 1
Form 4
+24.93%
3.77K
$4.97
$18,746.84
18.9K
Mar 1
Form 4
+32.26%
3.69K
$5.08
$18,745.20
15.13K
Dec 1
Form 4
+47.35%
3.68K
$5.10
$18,747.60
11.44K
Sep 1
Form 4
+33.33%
1.94K
$5.15
$9,996.15
7.76K
Jun 1
Form 4
—
0
—
—
0
May 24
Form 4
+37.95%
1.6K
$6.24
$9,996.48
5.82K
Mar 2
Form 4
+73.49%
1.79K
$5.59
$9,994.92
4.22K
Dec 1
Form 4
∞
2.43K
$4.11
$9,999.63
2.43K
Sep 1
Form 4
—
0
—
—
0
May 23
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Aug 5
No matching records found

NORTEL NETWORKS CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 30
Form 4
—
0
—
—
0
Sep 30
Form 4/A
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
No matching records found